N18

Chronic kidney disease (CKD)

Chronic kidney disease (CKD) represents a spectrum of pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR). It is defined as the presence of kidney damage or a GFR level less than 60 mL/min/1.73 m² for a period of three months or longer. CKD is classified into five stages based on the degree of renal impairment, with Stage 1 being the mildest and Stage 5 representing end-stage renal disease (ESRD). As the kidneys lose their ability to filter waste products from the blood and maintain fluid and electrolyte balance, patients may develop complications such as hypertension, anemia, metabolic bone disease, and cardiovascular complications. The progression of CKD often leads to a requirement for renal replacement therapy, such as hemodialysis, peritoneal dialysis, or kidney transplantation. Management focuses on slowing disease progression by controlling blood pressure, managing blood glucose in diabetic patients, and addressing associated cardiovascular risk factors.

Clinical Symptoms

  • Fatigue and general malaise
  • Peripheral edema (swelling of the ankles, feet, and hands)
  • Shortness of breath (due to fluid overload or anemia)
  • Persistent itching (pruritus)
  • Nausea and vomiting
  • Loss of appetite (anorexia)
  • Metallic taste in the mouth
  • Changes in urination frequency (nocturia or polyuria)
  • Decreased mental sharpness or cognitive fog
  • Muscle twitching and cramps
  • Chest pain (if pericarditis occurs)
  • High blood pressure (hypertension) that is difficult to control
  • Sleep disturbances and insomnia

Common Causes

  • Diabetes mellitus (Type 1 and Type 2)
  • Hypertension (High blood pressure)
  • Glomerulonephritis (inflammation of the kidney's filtering units)
  • Polycystic kidney disease
  • Prolonged obstruction of the urinary tract (from enlarged prostate, stones, or cancers)
  • Vesicoureteral reflux (urine backing up into the kidneys)
  • Recurrent kidney infections (pyelonephritis)
  • Interstitial nephritis (inflammation of the kidney's tubules and surrounding structures)
  • Systemic lupus erythematosus (lupus nephritis)
  • Chronic use of nephrotoxic medications (e.g., NSAIDs, certain antibiotics)

Documentation & Coding Tips

Specify the exact stage of Chronic Kidney Disease (CKD) based on the calculated glomerular filtration rate (eGFR). Avoid vague terms like renal insufficiency or renal failure without stage identification.

Example: Assessment and Plan: Patient presents with Stage 3b Chronic Kidney Disease as evidenced by a stable eGFR of 38 mL/min/1.73m2 over the last 6 months. Management includes continuation of ACE inhibitor with monitoring of serum potassium levels in 2 weeks. Billing Focus: Identification of the specific sub-stage (Stage 3b vs Stage 3a) supports N18.32 rather than the less specific N18.30. Risk Adjustment: Specific staging correlates directly with HCC 138 (Chronic Kidney Disease, Stage 3), influencing the complexity score for Medicare Advantage populations.

Billing Focus: Stage specificity (1, 2, 3a, 3b, 4, 5, or ESRD).

Always document the relationship between Chronic Kidney Disease and underlying conditions like Hypertension or Diabetes. ICD-10-CM assumes a causal relationship between HTN and CKD unless documented otherwise.

Example: Assessment: Hypertensive Chronic Kidney Disease, Stage 4. Patient has long-standing Essential Hypertension, currently 152/94, contributing to the progression of severe CKD (eGFR 22). Billing Focus: Combined code I12.0 (Hypertensive CKD Stage 5/ESRD) or I12.9 (Hypertensive CKD Stage 1-4) must be used. Risk Adjustment: Captures the additive risk of multi-system involvement in HCC models.

Billing Focus: Linkage of HTN or Diabetes to the renal condition.

Differentiate between Chronic Kidney Disease Stage 5 and End Stage Renal Disease (ESRD). Use ESRD only when the patient requires chronic dialysis or has reached the terminal phase of kidney failure.

Example: Diagnosis: End Stage Renal Disease (ESRD). Patient is currently receiving hemodialysis three times weekly via a left arteriovenous fistula. Most recent pre-dialysis labs show BUN 65 and Creatinine 7.2. Billing Focus: Code N18.6 for ESRD and Z99.2 for dependence on renal dialysis. Risk Adjustment: ESRD is a high-weight HCC (HCC 136) and triggers specialized payment models.

Billing Focus: Use of N18.6 for dialysis-dependent patients.

Document associated complications such as anemia of chronic kidney disease or secondary hyperparathyroidism to ensure comprehensive clinical picture and coding accuracy.

Example: Assessment: Stage 4 Chronic Kidney Disease with associated Anemia of CKD. Hemoglobin is 9.8 g/dL; initiating Epoetin alfa 10,000 units weekly. Billing Focus: Code D63.1 (Anemia in chronic kidney disease) requires the underlying CKD stage code (N18.x) to be sequenced first. Risk Adjustment: Anemia in CKD provides additional diagnostic complexity and supports higher intensity E/M leveling.

Billing Focus: Secondary diagnosis codes for complications.

For kidney transplant recipients, document both the transplant status and any remaining CKD in the graft or the native kidneys, if applicable.

Example: Assessment: Chronic Kidney Disease, Stage 2 (Mild) in a post-kidney transplant patient. Baseline creatinine 1.4, eGFR 65. Patient is stable on Tacrolimus and Mycophenolate. Billing Focus: Use N18.2 and Z94.0 (Kidney transplant status). Risk Adjustment: Transplant status (Z94.0) maps to HCC 186 (Kidney Transplant Status), which has significant risk weight.

Billing Focus: Concurrent use of status codes (Z codes).

Relevant CPT Codes

Related Diagnoses

Hierarchy